Cardamyst (etripamil)

Approved for To treat episodes of paroxysmal supraventricular tachycardia. 12.1 Mechanism of Action Etripamil is an L-type calcium influx inhibitor (slow channel blocker or calcium ion antagonist). Etripamil exerts its pharmacologic effect by modulating the influx of ionic… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS…

Loading full data from Know Your Drugs Institute…